IPO registrations (S-1, F-1) · Registrants

Cyteir Therapeutics, Inc.

SEC CIK
1662244 · filings on EDGAR ↗
Registration
Form S-1, first filed 2021-05-28, last 2021-06-14; 1 initial registration, 2 amendments
Outcome
Final prospectus filed 2021-06-21; declared effective 2021-06-17
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
P.O. BOX 80084, Stoneham, MA 02180
EIN
45-5429901
EDGAR entity type
operating
Insiders and CEO pay
Cyteir Therapeutics, Inc. on the corporate pages

Offering terms

Proposed price range
$16.00–$18.00 per share (S-1/A filed 2021-06-14)
Final price
$18.00 per share, within the range (424B4 filed 2021-06-21, an initial public offering)
Shares sold
7,400,000
Gross proceeds
$133,200,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CYT
Lead underwriters
J.P. Morgan; Morgan Stanley; BofA Securities
Syndicate
Wedbush Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
2021-05-28S-1S-1 (registration)Cyteir Therapeutics, Inc.0001193125-21-176892 ↗
2021-06-04S-1/AS-1/A (amendment)Cyteir Therapeutics, Inc.0001193125-21-182985 ↗
2021-06-14S-1/AS-1/A (amendment)Cyteir Therapeutics, Inc.0001193125-21-189385 ↗
2021-06-17EFFECTEFFECT (declared effective)Cyteir Therapeutics, Inc.9999999995-21-002394 ↗
2021-06-21424B4424B4 (final prospectus)Cyteir Therapeutics, Inc.0001193125-21-194049 ↗
2022-08-16EFFECTEFFECT (declared effective)Cyteir Therapeutics, Inc.9999999995-22-002401 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2021-06-14S-1/Aregistration statement$16.00–$18.007,400,000-Nasdaq CYT4primary document; range, shares headline, cover names 4document ↗
2021-06-21424B4final prospectus$18.007,400,000$133,200,000Nasdaq CYT4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bracken RacquelDirector32021–2023
DF II GP SarlTenPercentOwner22021
Droia Invest II SCSpTenPercentOwner22021
Gaiero David GOfficerChief Financial Officer; Vice President, Finance72021–2024
Gengos AndrewOfficerChief Business Officer22021–2022
George JeanDirector52021–2024
Hong KarenDirector12021
IHL SATenPercentOwner22021
Molineaux SusanDirector32021–2023
Naesens JanwillemDirector; TenPercentOwner52021–2022
Novo Holdings A/STenPercentOwner102021–2023
RENSCHLER MARKUS MDDirector,OfficerPresident and CEO; See Remarks72021–2024
Romberger TimothyDirector42021–2023
Secrist John PaulOfficerChief Scientific Officer22021–2022
Venrock Associates VII, L.P.TenPercentOwner22021
Venrock Management VII, LLCTenPercentOwner22021
Venrock Partners VII, L.P.TenPercentOwner22021
Verelst LucTenPercentOwner22021
Wepaven BVTenPercentOwner22021
Zakrzewski Joseph SDirector122021–2024
Humphrey JeffreyDirector42021–2023
THERO JOHN FDirector52022–2024
Sands Stephen H.Director42022–2024
Veness Adam MOfficerGeneral Counsel32022–2023
Leonard Braden MichaelTenPercentOwner32024

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2021-02-17Cyteir Therapeutics, Inc.BiotechnologyIndefinite$79,999,980221
2019-10-15Cyteir Therapeutics, Inc.BiotechnologyIndefinite$20,200,00061
2018-03-28Cyteir Therapeutics, Inc.Biotechnology$35,000,000$5,833,326122
2015-12-30Cyteir Therapeutics, Inc.Other Health Care$5,817,996$5,817,996152

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Plan sponsorCYTEIR THERAPEUTICSMAForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientCYTEIR THERAPEUTICS, INC.MAFederal spending (USAspending)name and state
Form D issuerCyteir Therapeutics, Inc.MAForm D private offeringsCIK (EXACT)
Patent assigneeCyteir Therapeutics, Inc.MAPatents (USPTO)name and state
SEC filerCyteir Therapeutics, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerCyteir Therapeutics, Inc.MATrademarks (USPTO)name and state
Form 5500 plan sponsorCYTEIR THERAPEUTICSEIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health